FMP

FMP

Enter

BMY - Bristol-Myers Squibb...

Financial Summary of Bristol-Myers Squibb Company(BMY), Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceuti

photo-url-https://financialmodelingprep.com/image-stock/BMY.png

Bristol-Myers Squibb Company

BMY

NYSE

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

48.3 USD

0.46 (0.952%)

About

ceo

Dr. Christopher S. Boerner Ph.D.

sector

Healthcare

industry

Drug Manufacturers - General

website

https://www.bms.com

exchange

NYSE

Description

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphi...

CIK

0000014272

ISIN

US1101221083

CUSIP

110122108

Address

430 East 29th Street

Phone

212 546 4000

Country

US

Employee

34,100

IPO Date

Jun 1, 1972

Summary

CIK

0000014272

Exchange

NYSE

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

110122108

ISIN

US1101221083

Country

US

Price

48.3

Beta

0.39

Volume Avg.

15.85M

Market Cap

97.89B

Shares

-

52-Week

47.58-70.94

DCF

464.62

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

12.51

P/B

-

Website

https://www.bms.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest BMY News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep